EMPA Acute Heart Failure

NCT03554200 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped COVID 19

Conditions

Diabetes Mellitus, Type 2
Acute Heart Failure

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

RWTH Aachen University

Collaborators

[object Object]